Literature DB >> 19116901

Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction.

Rebecca L Rudominer1, Mary J Roman, Richard B Devereux, Stephen A Paget, Joseph E Schwartz, Michael D Lockshin, Mary K Crow, Lisa Sammaritano, Daniel M Levine, Jane E Salmon.   

Abstract

OBJECTIVE: Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with premature atherosclerosis, vascular stiffening, and heart failure. This study was undertaken to investigate whether RA is associated with underlying structural and functional abnormalities of the left ventricle (LV).
METHODS: Eighty-nine RA patients without clinical cardiovascular disease and 89 healthy matched controls underwent echocardiography, carotid ultrasonography, and radial tonometry to measure arterial stiffness. RA patients and controls were similar in body size, hypertension and diabetes status, and cholesterol level.
RESULTS: LV diastolic diameter (4.92 cm versus 4.64 cm; P<0.001), mass (136.9 gm versus 121.7 gm; P=0.004 or 36.5 versus 32.9 gm/m2.7; P=0.01), ejection fraction (71% versus 67%; P<0.001), and prevalence of LV hypertrophy (18% versus 6.7%; P=0.023) were all higher among RA patients versus controls. In multivariate analysis, presence of RA was an independent correlate of LV mass (P=0.004). Furthermore, RA was independently associated with presence of LV hypertrophy (odds ratio 4.14 [95% confidence interval 1.24, 13.80], P=0.021). Among RA patients, age at diagnosis and disease duration were independently related to LV mass. RA patients with LV hypertrophy were older and had higher systolic pressure, damage index scores, C-reactive protein levels, homocysteine levels, and arterial stiffness compared with those without LV hypertrophy.
CONCLUSION: The present results demonstrate that RA is associated with increased LV mass. Disease duration is independently related to increased LV mass, suggesting a pathophysiologic link between chronic inflammation and LV hypertrophy. In contrast, LV systolic function is preserved in RA patients, indicating that systolic dysfunction is not an intrinsic feature of RA.

Entities:  

Mesh:

Year:  2009        PMID: 19116901      PMCID: PMC2626148          DOI: 10.1002/art.24148

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  47 in total

Review 1.  Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?

Authors:  S Van Doornum; G McColl; I P Wicks
Journal:  Arthritis Rheum       Date:  2002-04

Review 2.  Nails in the coffin: increasing evidence for the role of rheumatic disease in the cardiovascular mortality of rheumatoid arthritis.

Authors:  P A Bacon; J N Townend
Journal:  Arthritis Rheum       Date:  2001-12

Review 3.  Inflammatory mediators and the failing heart: past, present, and the foreseeable future.

Authors:  Douglas L Mann
Journal:  Circ Res       Date:  2002-11-29       Impact factor: 17.367

Review 4.  Proinflammatory cytokines.

Authors:  C A Dinarello
Journal:  Chest       Date:  2000-08       Impact factor: 9.410

5.  Diastolic function abnormalities in rheumatoid arthritis. Evaluation By echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease.

Authors:  M Di Franco; M Paradiso; A Mammarella; V Paoletti; G Labbadia; L Coppotelli; E Taccari; A Musca
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

6.  Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults.

Authors:  M J Roman; T G Pickering; J E Schwartz; R Pini; R B Devereux
Journal:  J Am Coll Cardiol       Date:  1996-09       Impact factor: 24.094

7.  Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study.

Authors:  P Verdecchia; G Carini; A Circo; E Dovellini; E Giovannini; M Lombardo; P Solinas; M Gorini; A P Maggioni
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

8.  Myocardial hypertrophy in transgenic mice overexpressing human interleukin 1alpha.

Authors:  K Isoda; Y Kamezawa; N Tada; M Sato; F Ohsuzu
Journal:  J Card Fail       Date:  2001-12       Impact factor: 5.712

9.  The number of deformed joints as a surrogate measure of damage in rheumatoid arthritis.

Authors:  Carlos H Orces; Inmaculada Del Rincón; Michael P Abel; Agustín Escalante
Journal:  Arthritis Rheum       Date:  2002-02

10.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I.

Authors:  Charles G Helmick; David T Felson; Reva C Lawrence; Sherine Gabriel; Rosemarie Hirsch; C Kent Kwoh; Matthew H Liang; Hilal Maradit Kremers; Maureen D Mayes; Peter A Merkel; Stanley R Pillemer; John D Reveille; John H Stone
Journal:  Arthritis Rheum       Date:  2008-01
View more
  31 in total

Review 1.  Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure.

Authors:  Kerry Wright; Cynthia S Crowson; Sherine E Gabriel
Journal:  Heart Fail Clin       Date:  2014-01-10       Impact factor: 3.179

2.  Absence of Fibrosis and Inflammation by Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients with Low to Moderate Disease Activity.

Authors:  William Bradham; Michelle J Ormseth; Comfort Elumogo; Srikanth Palanisamy; Chia-Ying Liu; Mark A Lawson; Jonathan H Soslow; Nadine Kawel-Boehm; David A Bluemke; C Michael Stein
Journal:  J Rheumatol       Date:  2018-04-15       Impact factor: 4.666

3.  Five-year changes in cardiac structure and function in patients with rheumatoid arthritis compared with the general population.

Authors:  John M Davis; Grace Lin; Jae K Oh; Cynthia S Crowson; Sara J Achenbach; Terry M Therneau; Eric L Matteson; Richard J Rodeheffer; Sherine E Gabriel
Journal:  Int J Cardiol       Date:  2017-03-31       Impact factor: 4.164

4.  Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study.

Authors:  Giovanni Cioffi; Ombretta Viapiana; Federica Ognibeni; Andrea Dalbeni; Davide Gatti; Silvano Adami; Carmine Mazzone; Giorgio Faganello; Andre Di Lenarda; Maurizio Rossini
Journal:  Herz       Date:  2015-05-20       Impact factor: 1.443

5.  Comparison of symptoms, treatment, and outcomes of coronary artery disease among rheumatoid arthritis and matched subjects undergoing percutaneous coronary intervention.

Authors:  Sonali P Desai; James L Januzzi; Ashvin N Pande; Eugene V Pomerantsev; Frederic S Resnic; Anne Fossel; Lori B Chibnik; Daniel H Solomon
Journal:  Semin Arthritis Rheum       Date:  2010-06-11       Impact factor: 5.532

6.  Effect of hypertension on echocardiographic parameters in rheumatoid arthritis.

Authors:  A Temiz; S Ozcan; F Gökmen; E Gazi; A Barutcu; A Bekler; B Altun; A Akbal; F Güneş; H Şen
Journal:  Z Rheumatol       Date:  2014-12       Impact factor: 1.372

7.  Epicardial adipose tissue thickness, flow-mediated dilatation of the brachial artery, and carotid intima-media thickness: Associations in rheumatoid arthritis patients.

Authors:  A Temiz; F Gökmen; E Gazi; A Akbal; A Barutçu; A Bekler; B Altun; Y Z Tan; F Güneş; H Şen
Journal:  Herz       Date:  2014-08-21       Impact factor: 1.443

8.  Rheumatoid arthritis patients with active disease and no history of cardiac pathology have higher brain natriuretic peptide (BNP) levels than patients with inactive disease or healthy control subjects.

Authors:  D J Armstrong; P V Gardiner; M J O'Kane
Journal:  Ulster Med J       Date:  2010-05

9.  Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study.

Authors:  Elena Myasoedova; John M Davis; Cynthia S Crowson; Véronique L Roger; Barry L Karon; Daniel D Borgeson; Terry M Therneau; Eric L Matteson; Richard J Rodeheffer; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2013-07

Review 10.  Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Mauro Galeazzi; Franco Laghi-Pasini
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.